在无形性皮肤炎中达到明星:有效性,安全性,耐受性,可访问性和缓解/缓解效应 (ESTAR)
1Ms. An is with the University of California, Irvine School of Medicine in Irvine, California.
The Journal of clinical and aesthetic dermatology
|December 25, 2025
概括
通过评估治疗疗效,安全性,耐受性,可访问性和缓解效应,ESTAR框架有助于管理亚托皮性皮肤炎 (AD). 这种以患者为中心的方法有助于优化护理,并提高对慢性皮肤病管理的坚持.
科学领域:
- 皮肤病学 皮肤病学
- 临床医学 临床医学
- 药物经济学 药物经济学
背景情况:
- 亚托皮炎 (AD) 是一种普遍的慢性炎症性皮肤病,影响全球数百万人.
- 阿尔茨海默病严重降低了患者的生活质量,原因是复发和持续的症状.
- 目前的管理策略需要加强共享决策的工具.
研究的目的:
- 引入ESTAR (有效性,安全性,耐受性,可访问性和缓解/缓解效应) 框架.
- 为评估新兴AD疗法提供现代化,以患者为中心的工具.
- 为了促进临床医生和患者在AD管理中的共同决策.
主要方法:
- 评论提出了ESTAR框架作为一个全面的评估工具.
- 它强调评估关键因素:疗效 (发病,深度,耐用性,可靠性),安全性,耐受性和缓解潜力.
- 建议使用雷达图来可视化和比较治疗选择.
主要成果:
- ESTAR框架为评估AD治疗提供了一个结构化的方法.
- 它平衡了即时的症状缓解与长期的疾病控制.
- 该框架旨在改善治疗坚持性和优化患者的治疗结果.
结论:
- ESTAR框架为导航复杂的AD治疗选择提供了有价值的工具.
- 它促进了以患者为中心的方法,增强了共享决策.
- 实施ESTAR可以改善阿托皮性皮肤炎患者的管理和治疗结果.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Dose-Response Relationship: Potency and Efficacy
6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205


